CAM
GILD icon

Claret Asset Management’s Gilead Sciences GILD Stock Holding History

Claret Asset Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,403
Closed -$206K – 157
2022
Q4 		$206K Buy
+2,403
New +$190K 0.05% 130
2018
Q4 		– Sell
-2,920
Closed -$225K – 207
2018
Q3 		$225K Buy
+2,920
New +$221K 0.04% 173

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Claret Asset Management's GILD Position: Q1 2023 in Review

Claret Asset Management sold out of Gilead Sciences (GILD) in Q1 2023, closing a stake of 2,403 shares — an estimated $206K sold.

Claret Asset Management first reported a position in GILD in Q3 2018 and held it in 2 quarters. The position peaked at $225K in Q3 2018. 1,735 funds tracked by Wall St. Rank hold GILD as of Q1 2023.

  • Claret Asset Management reported no remaining Gilead Sciences position as of Q1 2023 after selling out during the quarter.
  • Claret Asset Management sold 2,403 Gilead Sciences shares in Q1 2023, an estimated $206K.
  • Claret Asset Management first reported a position in Gilead Sciences in Q3 2018 and held it in 2 quarters.
  • Claret Asset Management's Gilead Sciences position peaked at $225K in Q3 2018.
  • 1,735 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2023.

Based on Claret Asset Management's 13F filing for Q1 2023, filed 18 Apr 2023.